Crofelemer
1 NDC across 1 manufacturer|0 Generic,1 Brand
Crofelemer is used to treat diarrhea, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 31, 2012. In 2024, Medicare Part D spent $8 million on Crofelemer across 2,591 claims for 376 beneficiaries.
Crofelemer is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $35.73 to $35.73 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$35.73 – $35.73
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing CROFELEMER
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MYTESI 125 MG DR TABLET | $35.7266 per EA | — |
Frequently Asked Questions
What is Crofelemer used to treat?
Crofelemer is used to treat diarrhea, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Crofelemer?
In 2024, Medicare Part D spent $8 million on Crofelemer across 2,591 claims for 376 beneficiaries.
How many Crofelemer products are on the market?
The Crofelemer drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Crofelemer?
NADAC reference prices for Crofelemer range from $35.7266 to $35.7266 per EA.
Which manufacturers make Crofelemer?
1 manufacturer lists Crofelemer in NADAC. Ranked by number of NDCs, the largest are Napo Pharmaceuticals, Inc. (1).